Developments in allogeneic peripheral blood progenitor cell transplantation

British Journal of Haematology

Volumn 103, Issue 3, 1998, Pages 594-600

  Russell, N H ^a,b   Gratwohl, A ^c   Schmitz, N ^d  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

Allograft; G CSF; Outcome; PBSCT; Stem cells

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE;

BONE MARROW TRANSPLANTATION; CELL SELECTION; CLINICAL TRIAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RELAPSE; REVIEW; SURVIVAL;

EID: 0031787530     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01024.x     Document Type: Review

References (59)

1. Anderlini, P., Korbling, M., Dale, D., Gratwhol, A., Schmitz, N., Stroncek, D., Howe, C., Leitman, S., Horowitz, M., Gluckman, E., Rowley, S., Przepiorka, D. & Champlin, R. (1997) Allogeneic blood stem cell transplantation: consideration for donors. Blood. 90, 903-908.
2. Aversa, F., Tabilio, A., Terenzi, A., Velardi, A., Falzetti, F., Giannoni, C., Iacucci, R., Zei, T., Martelli, M., Gambeluinghe, C., Rossetti, M., Caputo, P., Latini, P., Arestei, C., Raymondi, C., Reisner, Y. & Martelli, M. (1994) Successful engraftment of T-cell depleted 'three loci' incompatible transplants in leukemia patients by addition of granulocyte colony-stimulating factor mobilised peripheral blood progenitor cells to bone marrow inoculum. Blood. 84, 3948-3955.
3. Aversa, E. Terenzi, A., Tabulo, A., Velardi, A., Cunningham, I., Falzetti, F., Ruggeri, L., Carotti, A., Falcinelli, F., Reisner, Y. & Martelli, M. (1997) Megadose stem cell transplants from HLA-haploidentical 3-loci mismatched family donors. Blood, 90, (Suppl. 1 ). 471.
4. Azevedo, W., Aranha, F., Gouvea, J., Vigorito, A., Marques, J., Eid, K., Azevedo, A. & Souza, C. (1995) Allogeneic transplantation with blood stem cells mobilised by rh-GCSF for hematological malignancies. Bone Marrow Transplantation, 16, 647-653.
5. + selected cells in patients with advanced malignancies: severe immunodeficiency and related complications. British Journal of Haematology. 98, 760-766.
6. Becker, P.S., Wagle, M., Matous, S., Swanson, R., Pihan, G., Lowry, P.A., Stewart, F. & Heard, S. (1997) Spontaneous splenic rupture following administration of granulocyte-colony stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biology of Blood and Marrow Transplantation, 3, 45-49.
7. Beelen, D., Ottinger, H., Elmaagachli, A., Scheulen, B., Basu, O., Kremens, B., Haver, S., Grosse-Wilde, H. & Schaefer, U. (1997) Transplantation of filgrastim-mobilised peripheral blood stem cells from HLA-identical siblings or alternative family donors in patients with hematological malignancies: a prospective comparison on clinical outcome, immune reconstitution and hematopoietic chimerism. Blood, 90, 4725-4735.
8. + peripheral blood stem cells in patients with advanced hematologic malignancy. Blood. 88, 4132-4138.
9. Bensinger, W., Rowley, S. & Mills, B. (1998) CD34 enriched allogeneic peripheral blood stem cells used for transplantation. Bone Marrow Transplantation 21. (Suppl. 3), S102.
10. Bensinger, W., Weaver, C., Appelbaum, F., Rowley, W., Demirer, T., Sanders, J., Storb, R. & Buckner, CD. (1995) Transplantation of allogeneic peripheral blood stem cells mobilised by recombinant human granulocyte colony-stimulating factor. Blood, 85, 1655-1658.
11. Bensinger, W.I., Clift, T., Martin, P., Appelbaum, F., Demier, T., Gooley, T., Lilleby, K., Rowley, S., Sanders, J., Storb, R. & Buckner, C.D. (1996a) Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood, 88, 2794-2800.
12. Cleaver, S. & Goldman, J. (1998) Use of G-CSF mobilisation of peripheral blood stem cells in normal healthy donors: an international survey. Bone Marrow Transplantation 21, (Suppl. 3), 29-31.
13. Dreger, P., Haferlach, T., Echstein, V., Jacobs, S., Suttorp, M., Loftler, M., Mullerruchholtz, W. & Schmitz, N. (1994) C-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization and composition of the graft. British Journal of Haematology, 87, 609-613.
14. Dreger, P., Suttorp, M., Haferlach, T., Loffler, H., Schmitz, N. & Schrogens, W. (1993) Allogeneic granulocyte colony-stimulating factor mobilised peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood, 81, 1404-1407.
15. Fischer, J., Frick, M., Herda, A., Kusnierz-Glaz, C., Heyll, A. & Wernet, P. (1998) Primary unrelated allografting by G-CSF mobilised PBPC. Bone Marrow Transplantation 21, (Suppl. 3), S112.
16. - enriched cells of Th-2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood, 84, 3540-3547.
17. Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondon, G., Anderlini, P., O'Brien, S., Khoun, I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Beran, M., Przepiorka, D., Koller, C., Kornblau, S., Korbling, M., Keating, M., Kantarjian, H. & Champlin, R. (1997) Engraftment of allogeneic hematopoietic progenitor cells with purine-analog-containing chemotherapy: harnessing graft versus leukemia without myeloablative therapy. Blood, 89, 4531-4536.
18. Glass, B., Uharek, L., Zeis, M., Dreger, P., Loffler, H., Steinman, J. & Schmitz, N. (1997) Allogeneic peripheral blood progenitor cell transplantation in a murine model: evidence for an improved graft versus leukemia effect. Blood, 90, 1694-1700.
19. Gratwohl, A., Passweg, J., Baldomero, H. & Hermans. J. (1998) Blood and marrow transplantation activity in Europe 1996. Bone Marrow Transplantation. 22, 227-240.
20. Grigg, A., Roberts, A.W. & Raunow, H. (1995) Optimising dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilisation and collection of peripheral blood progenitor cells in normal volunteers. Blood. 86, 4437-4445.
21. Kernan, N., Collins, N., Juliano, L., Cartagena, T., Dupont, B. & O'Reilly, P (1986) Clonable T-lymphocytes in T-cell depleted bone marrow transplants correlate with development of graft versus host disease. Blood, 68, 770-775.
22. (-) progenitor cells and lymphoid subsets in normal stem cell donors for allogeneic transplantation. Bone Marrow Transplantation, 18, 1073-1079.
23. dim) and lymphoid subsets and possible prediction of engraftment and graft versus host disease. Blood, 86, 2842-2848.
24. Korbling, M., Mirza, N., Przepiorka, D., Anderlini, P., Chan, K. & Champlin, R. (1997) Clinical outcome of 112 patients following HLA-identical allogeneic peripheral blood stem cell transplantation. Blood, 10, (Suppl. 1). 224a.
25. Korbling, M., Przepiorka, D., Huh, H.D., Seong, D., Deisseroth, A.B., Andreeff, M. & Champlin, R. (1995b) Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: probable advantage of blood over marrow allografts. Blood, 85, 1659-1665.
26. + donor cells fail to induce experimental acute graft versus host disease. Journal of Immunology, 155, 585-592.
27. + cells mobilised into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood, 89, 1189-1196.
28. + blood cells. Blood, 87, 4903-4909.
29. Link, H., Arseniev, L., Llungman, P., Alessandrino, E.P., Amadori, S., Bandini, G., Beguin, Y., Brinch, L., Brunet, S., Chopra, R., Cordonnier, C., De Witte, T., Fauser, A., Ferrant, A., Garcia-Conde, J., Juliusson, G., Kubel, M., Manna, A.T., Martinez-Rubio, A.M., Mundhenk, P., Ordemann, R., Ortega, J.J., Potter, M., Prentice, H.G., Raimondi, R., Remez, K., Reusser, P., Rovira, M., Russell, J., Selleslag, D., Uderzo, C. & Zaucha, J.M. (1998) Cytomegalovirus infections after allogeneic peripheral blood progenitor cell transplantation: a survey of the infectious disease working party of the EBMT. Bone Marrow Transplantation, 21, (Suppl. 1), 5139.
30. Majolino, I., Saglio, G., Scime, R., Serra, A., Cavallaro, A., Fiandaca, T., Vasta, S., Pampinella, M., Catonia, P., Indovina, A., Marceno, R. & Santoro, A. (1996) High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplantation, 17, 555-560.
31. + cell dose predicts survival post-transplant morbidity and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood, 88, 3233-3238.
32. + cells derived from granulocyte colony-stimulating factor-mobilised peripheral blood mononuclear cells. Blood, 87, 1629-1634.
33. Mitlin, G., Charley, C., Stainer, C., Anderson, S., Hunter, A. & Russell, N.H. (1996) Stem cell mobilisation in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy. British Journal of Haematology. 95, 345-348.
34. Millin, G., Russell, N.H., Hutchinson, R., Morgan, G., Potter, M., Pagliuca, A., Marsh, J., Bell, A., Milligan, D., Lumley, M., Cook, G. & Franklin. I. (1997) Allogeneic peripheral blood stem cell transplantation for hematological malignancies: an analysis of kinetics of engraftment and GVHD risk. Bone Marrow Transplantation, 19, 9-13.
35. + peripheral blood progenitor cells. Blood, 88, (Suppl. 1), 987.
36. Nilsson, S.K., Dooner, M.S. & Quesenberry, P. (1997) Synchronised cell-cycle induction of engraftment long-term repopulating stem cells. Blood, 90, 4646-4650.
37. Offler, F., Schoch, G., Fisher, L., Torok-Storb. B. & Martin, P.J. (1996) Mortality hazard functions as related to neutropenia at different times after bone marrow transplantation. Blood, 88, 4058-4062.
38. Ottinger, H., Beelen, D., Scheulen, B., Schaefer, U. & Grosse-Wilde, H. (1996) Improved immune reconstitution after allotransplantation of peripheral blood stein cells instead of bone marrow. Blood, 88, 2775-2779.
39. Pan, L., Delmonte, J., Jalonen, C. & Ferrara, J. (1995) Pretreatment of donor mice with granulocyte-colony stimulating factor polarises T-lymphocytes towards type-2 cytokine production and reduced severity of experimental graft-versus-host disease. Blood, 86, 4422-4429.
40. Peters, S., Kittler, E., Ramshaw, H. & Quesenberry, P. (1996) Ex vivo expansions of murine cells with interleukin-3 (IL-3), IL-6, IL-11 and stem cell factor leads to impaired engraftment in irradiated hosts. Blood, 87, 30-37.
41. Prosper, F., Stroncek, D. & Verfaille, C.M. (1996) Phenotypic and functional characterization of long-term culture initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. Blood, 88, 2033-2042.
42. Reisner, Y. & Martelli, M. (1995) Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunology Today, 16, 437-440.
43. Ringden, O., Hagglund, H., Runde, V., Krochinsky, F., Stockschlaeder, M. & Potter, M. (1998) Transplantation of peripheral blood progenitor cells from unrelated donors. Bone Marrow Transplantation 21, (Suppl. 3), 81-84.
44. Roberts, A.W., Foote, S., Alexander, W.S., Scott, C., Robb, L. & Metcalf, D. (1997) Genetic influences determining progenitor cell mobilisation and leucocytosis induced by granulocyte colony stimulating factor. Blood, 89, 2736-2744.
45. Roberts, A.W. & Metcalf, D. (1995) Non-cycling state of peripheral blood progenitor cells mobilised by granulocyte-colony stimulating factor and other cytokines. Blood, 86, 1600-1605.
46. Russell, J., Brown, C., Bowen, T., Luider, J., Ruether, J.D., Stewart, D., Chaudhry, A., Booth, K., Jorgenson, K., Coppes, M.J., Poon, M.C. & Klassen, J. (1996) Allogeneic blood cell transplants for hematological malignancy: preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplantation. 17, 703-708.
47. Russell, J., Desai, S., Herbut, B., Brown, C., Luider, J., Ruether, J., Stewart, D., Chaudry, A., Booth, K., Jorgenson, K., Coppes, M., Turner, A., Larrat, J., Poon, M.-C. & Klassen, J. (1997) Partially mismatched blood cell transplants for high-risk hematologic malignancy. Bone Marrow Transplantation, 19, 861-866.
48. Russell, N.H., Gratwohl, A. & Schmitz, N. (1996) The place of blood stem cells in allogeneic transplantation. British Journal of Haematology, 93, 747-753.
49. Russell, N.H., Hunter, A.E., Rogers, S., Hanley, J. & Anderson, D. (1993) Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. (Letter). Lancet, 341, 1482.
50. Schmitz, N., Bacigalupo, A., Hasenclever, D., Nagler, A., GLuckman, E., Clark, P., Varet, B., Greinix, H., Frickhofen, N., Ringden, O., Zander, A., Apperley, J., Gorin, N., Borkett, K., Schwab, G., Goebel. M., Russell, N.H. & Gratwohl, A. (1998a) Allogeneic bone marrow transplantation versus filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukemia: results of a randomised multicentre study. Bone Marrow Transplantation. 21, 995-1004.
51. Schmitz, N., Dreger, P., Suttorp, M., Rohedder, E., Haferlach, T., Loffler, H., Hunter, A. & Russell, N.H. (1995) Primary transplantation of allogeneic peripheral blood progenitor cells mobilised by filgrastim (granulocyte colony-stimulating factor). (Letter). Blood, 85, 1666-1672.
52. Schmitz, N., Champlin, R., Horowitz, M. & Gratwohl, A. (1998b) Peripheral blood progenitor cell (PBPC) versus bone marrow (BM) transplants from HLA-identical donors: a joint analysis of the International Bone Marrow Transplant Registry (IBMTR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation 21, (Suppl. 1), S43.
53. Sierra, J., Storer, B., Hansen, J.A., Bjerke, J., Martin, P., Petersdorf, E., Appelbaum, F., Bryant, E., Chauncey, T., Sale, G., Sanders, J., Storb, R., Sullivan, K. & Anasetti, C. (1997) Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemia burden, donor HLA-matching and marrow cell dose. Blood, 89, 4226-4235.
54. Slavin, S., Nagler, A., Naparstek, E., Kapelusknik, Y., Aker, M., Cividalli, G., Varaldi, G., Kirschbaum, M., Ackerstein, E., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Elder, A. & Or, R. (1998) Non-myeloblative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood, 91, 756-763.
55. Storek, J., Gooley, T., Siadak, M., Bensinger, W., Maloney, D., Chauncey, T., Flowers, M., Sullivan, K., Witherspoon, R., Rowley, S., Hansen, J., Storb, R. & Appelbaum, F. (1997b) Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood, 90, 4705-4709.
56. Storek, J., Witherspoon, R., Maloney, D., Chauncey, T. & Storb, R. (1997a) Improved reconstitution of CD4 T-cells and B-cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow. (Letter). Blood, 89, 3891-3893.
57. Uharek, L., Hartung, G., Glass, B., Steinmann, J., Dreger, P & Schmitz, N. (1998) Superior antileukemic activity of murine peripheral blood progenitor cell grafts mobilised by G-CSF and stem cell factor compared to G-CSF alone. Bone Marrow Transplantation 21, (Suppl. 3), 16-20.
58. + selected cells from peripheral blood. Blood, 89, 3967-3973.
59. Zeng, D., Dejbakshn-Jones, S. & Strober, S. (1997) Granulocyte colony-stimulating factor reduced the capacity of blood mononuclear cells to induce graft versus host disease: impact on blood progenitor cell transplantation. Blood, 90, 453-460.